sheet 4 uni
Patient Information Leaflets (PIL)
Overview of Patient Information Leaflets (PIL)
Type of Document: Provides information related to medications prescribed or available from pharmacies.
Purpose: To guide patients in safely using their medication by informing them about:
How to take it safely.
Possible side effects.
Potential interactions with other substances.
Content of Patient Information Leaflet (PIL)
1. Identification of the Medicine
The leaflet contains key identifiers for the medication including:
Trade Name: The name under which the medicine is marketed.
Active Substance(s): The chemical component(s) responsible for the medication's therapeutic effect.
Pharmaceutical Dosage Form: The specific form the medication takes (e.g., tablet, syrup, etc.).
Strength: The concentration of the active substance in the dosage form.
2. Therapeutic Indication
Describes the authorized conditions or diseases for which the medicine can be used.
3. Necessary Information Before Taking the Medicine
Important warnings and information to consider which includes:
Contraindications: Situations when the medicine should not be used.
Precautions and Warnings: Notably regarding allergies.
Drug Interactions: Possible interactions with other medicines or food.
Special Patient Groups: Information pertinent to vulnerable populations e.g., pregnant or nursing mothers.
Effects on Driving: Any impact the medicine may have on the patient's ability to operate a vehicle safely.
4. Dosage Instructions
Detailed guidance on:
How to Take the Medicine: Includes both method and route of administration.
Frequency of Administration: Specifies how often the medication should be taken.
Duration of Treatment: Outlines how long the treatment should continue.
Missed Doses: Instructions on what to do if a dose is missed.
Withdrawal Effects: Risks associated with suddenly stopping the medication.
5. Description of Side Effects
Comprehensive listing of potential side effects, which should be:
Ordered by seriousness.
Listed by frequency of occurrence.
Includes actions to take if side effects are experienced.
6. Additional Information
Other relevant details, such as:
Excipients: Non-active ingredients involved in the formulation (e.g., binders, coatings).
Registered Pack Size: The available packaging sizes for the medication.
Storage Conditions: Instructions on how to store the medicine safely.
Manufacturer's Details: Name and address of the company that produces the medication.
7. Date of Leaflet Preparation
The leaflet should include the date it was produced and must be subject to revision for updates.
8. Language Requirements
Official Language: The PIL must be produced in the official language of the governing member state; other languages may also be included.
Clarity and Legibility: It must be written in clear, understandable terms, ensuring legibility for the users.
Example of a Consumer Medicine Information (CMI)
A typical CMI might have the following features:
Accurate and up-to-date.
Clear headings, simple instructions, and straightforward explanations.
Inclusion of sections such as:
Product Name and Generic Name
Product Use and Formulation
Dosage Instructions
Side Effects and Other Precautions.
Example: Leaflet for Brufen (Ibuprofen 200mg Tablets)
Important Points to Note:
Read Carefully: Users must read the leaflet thoroughly as it contains critical information.
Keep the Leaflet: Recommended for future reference.
Consult Healthcare Professional: Users should contact their doctor or pharmacist if uncertain about their symptoms or if they worsen.
Specifics in the Leaflet:
Indications: For mild to moderate pain relief, fever reduction, and anti-inflammatory uses.
Typically used for conditions such as arthritis and menstrual pain.
Effective usually within 30 minutes of administration.
Contraindications Include:
Allergies to ibuprofen.
Late-stage pregnancy (last three months).
Severe liver, kidney disease, severe heart failure.
Previous stomach ulcers or bleeding issues.
Food and Drink Considerations:
Can be taken with food or drinks; faster relief occurs on an empty stomach.
Caution with alcohol, which may amplify side effects.
Pregnancy and Breastfeeding:
Not recommended in the last trimester of pregnancy.
Should be discussed with a healthcare professional if breastfeeding or planning pregnancy.
Conclusion
The PIL offers vital information designed to ensure patient safety and medication efficacy. Understanding and adhering to its contents is crucial for proper medication management.